Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
104
NCT03630939
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Aug 9, 2018
Completion: Jun 12, 2019
NCT05465590
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Phase: Early Phase 1
Start: Dec 31, 2022
Completion: Dec 31, 2024